-
Posting Date: 04/02/2025
ASCA: Must an Administrative Simplification Compliance Act waiver be mailed or can it be faxed?
-
Posting Date: 04/02/2025
Are unclassified drug codes included in average sales price (ASP) files?
-
Posting Date: 04/02/2025
How do I bill a bilateral joint injection and HCPCS J1040 for two units?
-
Posting Date: 04/02/2025
Do all established drug HCPCS codes require the dosage amount in its description on the claim?
-
Posting Date: 04/02/2025
Implantable Continuous Glucose Monitors (I-CGM)
Implantable Continuous Glucose Monitors (I-CGM) N/A L38623 https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=38623 A58116 https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=58116 A58342 [...]
Read More -
Posting Date: 04/02/2025
MEDICAL REVIEW: Where can I find more details about the reasons my claims were denied?
-
Posting Date: 04/02/2025
MEDICAL REVIEW: How do I sign up for the CMS and NGS Listserv messages?
-
Posting Date: 04/02/2025
MEDICAL REVIEW: I am under TPE review and my claims were denied, who can I speak to about this?
-
Posting Date: 05/20/2024
Additional Events Links
Resources Education Partnership Request Form Five Steps to Webinar Success Provider Outreach and Education Reminders
Read More -
Posting Date: 03/15/2024
Additional Events Links
Resources Education Partnership Request Form Five Steps to Webinar Success Provider Outreach and Education Reminders
Read More -
Posting Date: 01/03/2025
Billing and Coding: Eculizumab
Billing and Coding: Eculizumab drug, hemolysis A54548 https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=54548 J1299, Q5151, Q5152
Read More -
Posting Date: 04/04/2023
Billing and Coding: Ranibizumab, Aflibercept and Brolucizumab-dbll and Faricimab-svoa
Billing and Coding: Ranibizumab, Aflibercept and Brolucizumab-dbll and Faricimab-svoa eye, ophthalmology, macular A52451 https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=52451 C9399, J0177, J0178, J0179, J2777, J2778, [...]
Read More -
Posting Date: 04/02/2025
Amniotic/Placental-Derived Product Injections/Applications for Musculoskeletal Indications, Non-Wound
Amniotic/Placental-Derived Product Injections/Applications for Musculoskeletal Indications, Non-Wound L39139 https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdId=39139 A58893 [...]
Read More -
Posting Date: 03/16/2022
Telehealth Services
Telehealth Services Table of Contents General Information Originating Site Distant Site List of Covered Medicare Telehealth Services Billing Facility Fee for Originating Site Payment for Professional Fee Place of [...]
Read More